Related Experiment Videos

[Clinical effect of cephems: cefoperazone in the treatment of postoperative infections]

Insights

Cefoperazone (CPZ) demonstrates high effectiveness and bacterial eradication in postoperative and abdominal infections. This antibiotic shows promising results with no observed adverse laboratory effects, making it a valuable treatment option.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Microbiology

Context:

  • Postoperative wound infections
  • Abdominal cavity infections
  • Antibiotic resistance challenges

Purpose:

  • Evaluate the clinical efficacy and bacteriological effect of Cefoperazone (CPZ)
  • Assess safety profile of CPZ in clinical settings
  • Determine CPZ's utility against challenging pathogens like Pseudomonas sp. and Enterobacter sp.

Summary:

  • Cefoperazone (CPZ) exhibited 100% effectiveness in postoperative wound infections and 71.4% in abdominal infections.
  • Bacteriological eradication rates for CPZ were 90% and 80% in postoperative and abdominal infections, respectively.
  • No significant adverse laboratory findings were reported, indicating a favorable safety profile for CPZ.

Impact:

  • Cefoperazone (CPZ) presents a highly effective therapeutic option for managing postoperative infections.
  • The broad-spectrum activity and safety profile of CPZ support its use against susceptible Gram-positive, Gram-negative, aerobic, and anaerobic organisms.
  • CPZ shows particular promise for infections caused by difficult-to-treat bacteria such as Pseudomonas sp. and Enterobacter sp.

Related Concept Videos